Á lódáil...

Brexanolone for the treatment of patients with postpartum depression

On March 19, 2019, the United States Food and Drug Administration (FDA) approved Zulresso (brexanolone) for intravenous use for the treatment of postpartum depression (PPD) in adult women. The decision was based on three recent clinical trials following an FDA priority review and breakthrough therap...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Drugs Today (Barc)
Main Authors: Morrison, K.E., Cole, A.B., Thompson, S.M., Bale, T.L.
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2019
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8033597/
https://ncbi.nlm.nih.gov/pubmed/31584571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1358/dot.2019.55.9.3040864
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!